$1000 prize for the best paper in Population Medicine by an HMS/HSDM student
Jane Huang is an Epidemiologist and Research Scientist in the Department of Population Medicine at Harvard Medical School and Harvard Pilgrim Health Care Institute. She is a pharmacist by training and received her PhD in Pharmaceutical Health Services Research from University of Maryland School of Pharmacy. Jane is actively engaged in the Sentinel Initiative, where she contributes scientific reviews to FDA's post-market safety surveillance of prescription medications and other medical products.
Dr. Garabedian is an Assistant Professor in the Department of Population Medicine (DPM) in the Division of Health Policy and Insurance Research (HPI). Her research is focused on the robust evaluation of global and domestic health insurance reforms, health care delivery system reforms and pharmaceutical policies using quasi-experimental and experimental research methods and routinely collected insurance claims and electronic medical record datasets.
Julia Marcus, PhD, MPH is an infectious disease epidemiologist and Assistant Professor in the Department of Population Medicine at Harvard Medical School and Harvard Pilgrim Health Care Institute, and Adjunct Faculty at The Fenway Institute. Her research focuses on HIV, hepatitis C, and other sexually transmitted infections, with a primary interest in the implementation of preexposure prophylaxis (PrEP) for HIV prevention.
Anjali Kaimal, MD, MAS is an Associate Professor in the Department of Obstetrics, Gynecology, and Reproductive Biology at Harvard Medical School and a Maternal-Fetal Medicine Specialist at Massachusetts General Hospital. Her research program is focused on the definition, design, execution, and dissemination of evidence-based, patient-centered interventions to improve the quality and effectiveness of obstetric care, particularly regarding mode of delivery and interventions during pregnancy including induction of labor, prenatal testing, and medications for management of medical complication
Sruthi Adimadhyam is a Research Scientist in the Department of Population Medicine at Harvard Medical School and the Harvard Pilgrim Health Care Institute. A pharmacoepidemiologist by training, her interests include evaluation and confirmation of post-marketing safety signals, comparative effectiveness research, and methods to mitigate bias in observational studies of newly approved medications. She currently works on the FDA-sponsored Sentinel Initiative monitoring post-marketing safety of regulated medical products. Dr.